Concord Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,417.75
14.7 (1.05%)
BSENSE

Dec 05

BSE+NSE Vol: 31.96 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Concord Biotech Ltd stock-summary
stock-summary
Concord Biotech Ltd
Small Cap
Pharmaceuticals & Biotechnology
Concord Biotech Limited was originally incorporated as `Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was changed to `Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 10.46 Cr
Number of Shares
10.46 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Jul-2022
10.46
10.46
9510564
1
Bonus Issue
08-Jul-2022
9.51
9.51
85595076
1
Stock Split
05-Jul-2016
95.11
9.51
305372
10
Preferential Allotment
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 24 Schemes (4.53%)

FIIs

Held by 102 FIIs (8.03%)

Promoter with highest holding

Sudhir Kumar Vaid (28.84%)

Highest Public shareholder

Aryavir Jhunjhunwala Discretionary Trust (8.03%)

Individual Investors Holdings

7.77%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
SUDHIR JAIRAM VAID
Chairman & Managing Director
5.02 cr
ANKUR VAID
Joint Managing Director & CEO
2.89 cr
Ravi Kapoor
Non Executive Director
2.2 lacs
Rajiv Agarwal
Nominee
2.2 lacs
Utpal Sheth
Nominee
70.0 k
Amit Varma
Nominee
0
BHARTI KHANNA
Independent Director
1.7 lacs
ANIL KATYAL
Independent Director
2.2 lacs
Amitabh Thakore
Independent Director
2.2 lacs
Arvind Agarwal
Independent Director
2.0 lacs
Jayaram Easwaran
Independent Director
2.0 lacs
Mandayam Chakravarthy Sriraman
Independent Director
1.5 lacs
S Prakash
Vice President & CS
37.8 lacs
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Material Consumed
264.3126
0%
 
100
Raw Material Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
247 Cr
(Quarterly Results - Sep 2025)
Net Profit:
64 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 14,832 Cr (Small Cap)

stock-summary
P/E

45.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.76%

stock-summary
Debt Equity

-0.18

stock-summary
Return on Equity

17.73%

stock-summary
Price to Book

8.01